Investment Summary

Polaris Partners Invests In Avitide

On March 15, 2013, growth capital firm Polaris Partners invested in life science company Avitide

Investment Highlights
  • This is Polaris Partners’ 5th transaction in the Life Science sector.
  • This is Polaris Partners’ 27th transaction in the United States.
  • This is Polaris Partners’ 1st transaction in New Hampshire.
Investment Fate
  • Avitide was sold to a publicly-traded strategic buyer in 2021 for 150M USD.

Investment Summary

Date 2013-03-15
Target Avitide
Sector Life Science
Investor(s) Polaris Partners
Deal Type Venture

Target

Avitide

Lebanon, New Hampshire, United States
Avitide is a chromatography developer with diverse affinity ligand libraries and best-in-class ligand-to-resin development timelines. Avitide was formed in 2012 and is based in Lebanon, New Hampshire.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Polaris Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1996
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.


DEAL STATS #
Overall 29 of 87
Sector: Life Science M&A 5 of 39
Type: Venture M&A Deals 11 of 57
State: New Hampshire M&A 1 of 1
Country: United States M&A 27 of 78
Year: 2013 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-04 US HealthVest

New York, New York, United States

US HealthVest is a provider of behavioral healthcare services. US HealthVest’s hospitals provide specialized psychiatric care to patients with a full range of inpatient and day hospital services for adolescents, adults and senior adults. US HealthVest was founded in 2012 and is based in New York, New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-01 Aepona

Belfast, United Kingdom

Aepona provides products and services to Telcos globally, enabling them to adopt the emerging Network as a Service (NaaS) business model and unleash the full power of their network assets.

Sell -